Chronic graft dysfunction in renal transplant patients: Potential role of plasminogen activator inhibitor type 1

Transplantation

Volumn 73, Issue 8, 2002, Pages 1290-1295

  Lahlou, Anis ^a   Peraldi, Marie Nolle ^b   Thervet, Eric ^c   Flahault, Antoine ^d   Delarue, Francoise ^a   Soubrier, Florent ^d   Rossert, Jerome ^d   Hertig, Alexandre ^a   Rondeau, Eric ^a,d  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BODY MASS; DNA POLYMORPHISM; FEMALE; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 0037181643     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200204270-00018     Document Type: Article

References (25)

1. Chronic allograft nephropathy: An update
2. Chronic renal allograft rejection: Immunologic and non-immunologic risk factors
3. Rethinking chronic allograft nephropathy: The concept of accelerated senescence
4. The plasminogen activator inhibitor type 1 as a potential target in renal fibrogenesis
5. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat
6. Prognostic value of plasminogen activator inhibitor-1 mRNA in microdissected glomeruli from transplanted kidneys
7. Allelespecific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
8. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity
9. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1
10. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients: Relationship with plasma insulin
11. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasmin insulin level and relative body weight in normal and obese subjects
12. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia
13. Prediction of creatinine clearance from serum creatinine
14. Tissue-type plasminogen activator activity in HIV-associated HUS
15. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy
16. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy
17. Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: Importance of ACE polymorphism
18. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy
19. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients
20. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels
21. Role of insulin resistance in human disease
22. The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation
23. Metabolic factors and outcome of organ transplantation
24. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis
25. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney